tiprankstipranks
Advertisement
Advertisement

CH:9EP Stock Latest News

Enanta reports Q2 EPS (45), consensus (49c)
The FlyEnanta reports Q2 EPS (45), consensus (49c)
27d ago
ENTA
ENTA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ENTA Earnings this Week: How Will it Perform?
29d ago
ENTA
Enanta announces first participant dosed in Phase 1 trial of EDP-978
PremiumThe Fly
Enanta announces first participant dosed in Phase 1 trial of EDP-978
2M ago
ENTA
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
PremiumCompany Announcements
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
2M ago
8K
ENTA
Enanta initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Enanta initiated with a Buy at Rodman & Renshaw
2M ago
ENTA
Enanta Shareholders Approve Board Elections and Equity Plan
PremiumCompany AnnouncementsEnanta Shareholders Approve Board Elections and Equity Plan
3M ago
8K
ENTA
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
Premium
Ratings
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
4M ago
ENTA
Enanta files $150M mixed securities shelf
Premium
The Fly
Enanta files $150M mixed securities shelf
4M ago
ENTA
Enanta reports Q1 EPS (42c), consensus (88c)
PremiumThe Fly
Enanta reports Q1 EPS (42c), consensus (88c)
4M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
4M ago
ENTA
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatings
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
7M ago
ENTA
Enanta Pharmaceuticals Reports Progress in Drug Development
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Progress in Drug Development
7M ago
ENTA
Enanta reports Q4 EPS (87c), consensus ($1.01)
PremiumThe FlyEnanta reports Q4 EPS (87c), consensus ($1.01)
7M ago
ENTA
Is ENTA a Buy, Before Earnings?
Premium
Pre-Earnings
Is ENTA a Buy, Before Earnings?
7M ago
ENTA
Buy Rating for Enanta Pharmaceuticals Driven by Promising RSV Drug Pipeline and Market Potential
Premium
Ratings
Buy Rating for Enanta Pharmaceuticals Driven by Promising RSV Drug Pipeline and Market Potential
7M ago
ENTA
Enanta initiated with an Overweight at JPMorgan
PremiumThe Fly
Enanta initiated with an Overweight at JPMorgan
7M ago
ENTA
Enanta Pharmaceuticals Announces Public Stock Offering
PremiumCompany Announcements
Enanta Pharmaceuticals Announces Public Stock Offering
8M ago
8K
ENTA
Enanta upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Enanta upgraded to Buy from Hold at Jefferies
8M ago
ENTA
Enanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral
PremiumThe Fly
Enanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral
8M ago
ENTA
Enanta 6.5M share Spot Secondary priced at $10.00
PremiumThe FlyEnanta 6.5M share Spot Secondary priced at $10.00
8M ago
ENTA
Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
Premium
The Fly
Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
8M ago
AIR
COP
Enanta $50M Spot Secondary; price range $10.00-$10.50
Premium
The Fly
Enanta $50M Spot Secondary; price range $10.00-$10.50
8M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >